Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas

Antonio Pellino, Stefano Brignola, Erika Riello, +19

Journal of Personalized Medicine

INFINITY: A multicentre, single-arm, multi-cohort, phase II trial of tremelimumab and durvalumab as neoadjuvant treatment of patients with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC).

Filippo Pietrantonio, Alessandra Raimondi, Sara Lonardi, +17

Journal of Clinical Oncology

Surgical OncologyCancer ManagementImmunologyGastroenterologyPathology +20

KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population

Marta Schirripa, Floriana Nappo, Chiara Cremolini, +13

Clinical Colorectal Cancer

OncologyGastrointestinal OncologyMedicinePathologyColorectal Cancer +7

Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

A. Raimondi, Sara Lonardi, Sabina Murgioni, +47

Annals of Oncology

Surgical OncologyEsophageal CancerGastrointestinal OncologyMedicineInfinity Study +8

PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study

Nicola Silvestris, Antonella Argentiero, Oronzo Brunetti, +11

Expert Opinion on Therapeutic Targets

Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma

Margherita Rimini, Teresa Macarulla, Valentina Burgio, +24

European Journal of Cancer

Surgical OncologyHepatologyClinical ImplicationMedicineHepatobiliary Tumor +9

Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study

Floriana Nappo, Lorenzo Fornaro, Luca Pompella, +20

Journal of Cancer Research and Clinical Oncology

Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors

Filippo Pietrantonio, Sara Lonardi, Francesca Corti, +19

Journal for ImmunoTherapy of Cancer

Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial

Giovanni Randon, Sara Lonardi, Matteo Fassan, +29

The Lancet Oncology

Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas

Andrea Mafficini, Emil Lou, Giuseppe Malleo, +20

Human Pathology

Tumor BiologyPancreatic CancerPathologyCancer GenomicsMedicine +2